Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 170 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Zarogoulidis, Konstantinos [Clear All Filters]
Following the crumbs: from tissue samples, to pharmacogenomics, to NSCLC therapy..
Transl Lung Cancer Res. 2(4), 256-8.
(2013). Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems..
Int J Pharm. 458(1), 39-47.
(2013). Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study..
Drug Des Devel Ther. 7, 611-7.
(2013). Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients..
Future Oncol. 9(9), 1307-13.
(2013). Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer..
Future Oncol. 9(8), 1171-94.
(2013). Interleukin-6 cytokine: a multifunctional glycoprotein for cancer..
Immunome Res. 9(62), 16535.
(2013). Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics..
Int J Pharm. 456(2), 325-31.
(2013). Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies..
Drug Des Devel Ther. 7, 571-83.
(2013). Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis..
J Mol Genet Med. 7, 65.
(2013). Lung cancer: an update on current and future diagnostic and treatment techniques..
J Thorac Dis. 5 Suppl 4, S341.
(2013). Lung cancer surgery: an up to date..
J Thorac Dis. 5 Suppl 4, S425-39.
(2013). Malignant pleural effusion and algorithm management..
J Thorac Dis. 5 Suppl 4, S413-9.
(2013). Malignant pleural mesothelioma: current and future perspectives..
J Thorac Dis. 5 Suppl 4, S397-406.
(2013). The management of the advanced colorectal cancer: management of the pulmonary metastases..
J Thorac Dis. 5 Suppl 4, S383-8.
(2013). Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today..
Onco Targets Ther. 6, 609-13.
(2013). Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy..
J Cancer. 4(9), 736-54.
(2013). Necrotizing sarcoid granulomatosis with hemoptysis: a case report and literature review..
Diagn Pathol. 8, 79.
(2013). New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer..
Ther Deliv. 4(10), 1221-3.
(2013). New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam..
Int J Pharm. 455(1-2), 182-8.
(2013). Occupational exposure and lung cancer..
J Thorac Dis. 5 Suppl 4, S440-5.
(2013). "One-stop shop" spectral imaging for rapid on-site diagnosis of lung cancer: a future concept in nano-oncology..
Int J Nanomedicine. 8, 4533-42.
(2013). Research spotlight: sirolimus-coated stents for airway tracheal stenosis: a future 3D model concept with today's knowledge..
Ther Deliv. 4(9), 1093-7.
(2013). The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis..
Onco Targets Ther. 6, 1493-500.
(2013). Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitis..
Drug Des Devel Ther. 7, 627-33.
(2013). Successful management of an inadvertent excessive treprostinil overdose..
Drug Des Devel Ther. 7, 161-5.
(2013).